No Data
Intco Medical Technology Co., Ltd.'s (SZSE:300677) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Selected Announcement: Oulai New Materials: plans to invest no less than 2.59 billion yuan to build the Oulai New Materials Mingyue Lake Industrial Park project; Intco Medical Technology: plans to repurchase company shares worth 80 million to 0.12 billion
Beijing Tianyishangjia New Material Corp.: Tianrendahe intends to cooperate with Xinghe Power in the research and development and manufacturing of solid and liquid launch vehicle related components.
GLE.FE Announcement Selection | Oulai New Materials: Intends to invest no less than 2.59 billion yuan to build Oulai New Materials Mingyue Lake Industrial Park project; Intco Medical Technology: Intends to repurchase company shares worth 80 million yuan t
[Company Business Data] Yunda Holding (002120.SZ): In August, the express service business income was 3.917 billion yuan, a year-on-year increase of 11.41%. sto express co.,ltd. (002468.SZ): In August, the express service business income was 3.873 billion yuan, a year-on-year increase of 21.5%. YTO Express Group (600233.SH): In August, the express product income was 4.908 billion yuan, a year-on-year increase of 20.67%. guilin layn natural ingredients corp. (002166.SZ): Net income is expected to increase by 100%-150% in the first three quarters. [Contract Projects] Oulei New Materials (688530.SH): Intends to be no less than 2.59 billion.
intco medical technology (300677.SZ): plans to repurchase company shares worth 80 million to 0.12 billion yuan.
On September 19, Intco Medical Technology (300677.SZ) announced that it plans to repurchase a total amount of shares not less than RMB 80 million and not exceeding RMB 120 million, with a maximum repurchase price of RMB 26.66 per share, for the purpose of implementing employee stock ownership plans and/or stock-based incentives.
The threat of additional tariffs looms high, intco medical technology's stock price drops by 20%, What are the prospects for its North American layout?
①Today, Intco Medical Technology's stock fell 20 centimeters in the intraday trading session. An employee from the securities department of Intco Medical Technology stated, 'This is because the United States announced the impact of increasing tariffs on some Chinese commodities under Section 301.' ②The employee said that the proportion of the U.S. market in the company's revenue is about 35%, which may pose challenges to the company's performance in the short term. However, the overall potential of the U.S. market is still significant, and the company still plans to increase its efforts to expand into the North American market.
Solid Earnings May Not Tell The Whole Story For Intco Medical Technology (SZSE:300677)
There's Reason For Concern Over Intco Medical Technology Co., Ltd.'s (SZSE:300677) PriceNo Data
No Data
